UnitedHealth Group Incorporated $UNH Stock: KMG Fiduciary Partners LLC Reduces Stake

KMG Fiduciary Partners LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,590 shares of the healthcare conglomerate’s stock after selling 1,365 shares during the quarter. KMG Fiduciary Partners LLC’s holdings in UnitedHealth Group were worth $2,786,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth $27,000. Wellington Altus USA Inc. increased its holdings in UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 33 shares during the last quarter. Lifetime Wealth Management P.C. purchased a new stake in UnitedHealth Group in the 4th quarter worth $29,000. Security National Bank of SO Dak bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $29,000. Finally, Aberdeen Wealth Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $31,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $378.59 on Wednesday. The company’s 50-day moving average price is $387.44 and its 200-day moving average price is $382.57. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a market cap of $339.82 billion, a PE ratio of 24.36, a price-to-earnings-growth ratio of 1.42 and a beta of 0.60. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%. The company had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the business posted $2.59 earnings per share. The firm’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 19.85 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is 59.72%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Argus lifted their target price on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Cantor Fitzgerald increased their price target on UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Wells Fargo & Company raised their price target on UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a report on Monday, July 13th. HSBC lifted their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research note on Monday, July 6th. Finally, Zacks Research cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $462.59.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.19% of the company’s stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings materially beat expectations. Adjusted earnings were $4.69 per share versus consensus estimates near $4.14, while revenue of approximately $112.7 billion also exceeded forecasts. Operating earnings increased 52% to $6.6 billion, supported by improved execution and lower medical costs. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: UnitedHealth raised its 2026 outlook. The company now expects adjusted earnings of at least $20.50 per share, above the roughly $19.86 consensus estimate. Management also indicated that Wall Street’s 2027 earnings expectations may be too conservative. UnitedHealth raises 2026 earnings outlook as quarterly operating profit jumps 52%
• Positive Sentiment: The turnaround strategy is showing progress. Management cited better margins, tighter cost controls, the exit from unprofitable patient groups and improving performance across the insurance and Optum businesses. AI tools reportedly reduced clinical-review times by 33%, potentially supporting longer-term efficiency gains. UnitedHealth Group Earnings Call Highlights Growth and AI
• Neutral Sentiment: Medicaid margins may have reached a trough. UnitedHealth expects core Medicaid margins to improve after 2026, with 2026 described as the likely bottom. This supports the recovery thesis but implies meaningful benefits may take time to appear. UnitedHealth Calls 2026 the Bottom for Medicaid Margins
• Negative Sentiment: Top-line growth remains weak. Quarterly revenue was roughly flat, or slightly lower, year over year, and reports noted softness in Optum Health revenue. Investors may therefore be looking for evidence that profit improvements can translate into sustained sales growth. UnitedHealth raises guidance as Optum Health revenue slips
• Negative Sentiment: The market reaction suggests a high bar for the recovery. UNH initially gained as much as roughly 5% before trimming those gains, indicating that investors may already have priced in part of the earnings recovery and remain cautious about medical-cost trends, Medicaid profitability and execution in 2027. UnitedHealth Group stock trims gains on profit outlook increase

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.